The ASH people emailed me today with a sneak
preview of their August newsletter. It is such a shame that the people who
produce these bulletins work in offices and so put so much emphasis on
paperwork trivia, but this one seems to be the exception…
Here’s a sneak preview of our August issue before it hits your mailbox. |
|
A Cure for Congress? Jason Westin, MD, a hematologist and researcher running for U.S. Congress in Texas' 7th district, shares why he decided to run and offers advice for colleagues who want to get involved in politics. |
|
Long-Term Study Confirms Durable Responses With Reduced-Intensity Conditioning AlloHCT in High-Risk CLL Ten-year follow-up data from the prospective phase II CLL3X trial confirms that patients with high-risk chronic lymphocytic leukemia can achieve durable responses with reduced-intensity conditioning allogeneic hematopoietic cell transplantation. |
|
Editor's Corner: Musing on Medical Marvels Keith Stewart, MBChB, MBA, acknowledges the hard work of every member of the “medical marvels” team – including Big Pharma. |
|
Here are some highlights from the July Bonus Mid-Year Edition: |
No comments:
Post a Comment